 1. Participants with a current diagnosis of epithelial ovarian tumor of low malignant potential Borderline carcinomas are not eligible. Participants with a prior diagnosis of a low malignant potential tumor that was surgically resected and who subsequently develop invasive adenocarcinoma are eligible, provided that they have not received prior chemotherapy for any ovarian tumor. 